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THE PRESENCE of circulating anti-
bodies to murine mammary tumour virus
(MuMTV) related antigens in mice as
well as in humans has been reported by
a number of investigators (Muller et al.,
1976; Priori et al., 1972; Hoshino &
Dmochowski 1973). Tumour growth, ac-
cording to a hypotheses of Nordquist et
al. (1977) is facilitated by antibody-
induced redistribution and shedding of
mammary-tumour antigens into the circu-
latory system. The antigen-denuded cells
are not then recognized by effector agents.
Efforts to inhibit mammary-tumour
growth and reduce its incidence in suscep-
tible strains of mice by immunization with
MuMTV were not successful (Charney et
al., 1976). Sarkar & Moore (1978), however,
have recently shown that C57BL mice
that were immunized with purified form-
alin-inactivated MuMTV showed increased
resistance to exogenous MuMTV infection,
and to subsequent development of mam-
mary tumours. They concluded that
successful immunization required the use
of relatively high doses of killed virus.
The recorded incidence of spontaneous-
tumour rejection by inbred mice is very
rare. Hewitt et al. (1976) found that, in
20,000 transplantations of different
tumours in WHT/iHt and CBA/Ht lines
of mice, only 2 cases of tumour rejection
occurred.
The purpose ofthis study was to explain
the repeated rejection of mouse mam-
mary-tumour implants by 2 mice in our
laboratory, and to determine whether
these mice produced antibody reactive
against human breast-tumour tissue.
In the course of 2 years, murine mam-
mary tumours derived from BALB/cf
C3H mice were implanted into 290 mice.
Tumours were allowed to grow to a size of
about 1 cm3 before s.c. transplantation of
2 pieces of tumour tissue (1 mm3) in the
lateral abdominal area of recipient mice.
The tumours were propagated in the
animals for 10 generations. Only 2 mice,
one in the 4th and the other in the 7th
generation, rejected the tumours. Three
separate attempts to implant tumours
were made in each mouse, without
success. At each attempt the same tumour
was successfully implanted into several
other mice.
Sera obtained by retro-orbital sinus
bleeding from the mice that rejected the
tumour, 8 healthy mice, and 3 tumour-
bearing mice from the same colony, were
absorbed with lyophilized human benign
breast-tumour tissue and examined for
the presence of antibodies to antigens
in human breast carcinomas. Sera from
the 2 mice that rejected the tumors re-
acted positively when tested by indirect
immunofluorescence for reactivity against
frozen sections of human breast adeno-
carcinomas. FITC-labelled anti-mouse IgG
serum from Meloy Laboratories was used
as the secondary antibody in the indirect
immunofluorescence assay. Sera from all
other mice were negative. All sera were
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negative when tested against sections of
human benign breast tumours. Positive
immunofluorescence was also seen when
sections ofhuman breast adenocarcinomas
were examined for reactivity with rabbit
anti-MuMTV serum. The results are shown
in the Table.
TABLE.-Reactivity of mouse sera with
human breast-tumour sections
No of
Origin of serum animals Benign Carcinoma
Mice rejecting
tumour 2 +
Healthy mice 8
Tumour-bearing
mice 3
Rabbit anti-
MuMTV +
The results of this investigation indicate
that sera from the mice that rejected the
mammary tumours contained antibodies
directed against antigens in human breast-
carcinoma tissue. The immunological re-
activity of sera from these mice was
similar to the reactivity of rabbit anti-
MuMTV sera when tested against sections
of human breast tumour. The sera of
control and tumour-bearing mice did not
possess this reactivity.
It has been previously shown (Muller
et al., 1976; Priori et al., 1972; Hoshino &
Dmochowski, 1973; Tomana et al., 1979)
that an imminological relationship exists
between mouse and human breast cancer.
Although the existence ofa human breast-
tumour virus is still questionable, compo-
nentsweredetected in human breast-carci-
nomapatientsthatareantigenicallyrelated
to a component of MuMTV. Although our
results suggest that the mice rejecting the
tumour had natural or spontaneously
acquired antibodies to MuMTV, it is
possible that the piece of tumour used for
the first implantation consisted of non-
viable tissue which resulted in immuniza-
tion of the mouse. Rejection of the 2nd
and 3rd implants that were done at
about one-month intervals could thus be
explained. This explanation is consistent
with previous findings of Sarkar & Moore
(1978) who demonstrated successful im-
munization of mice with formalin-treated
MuMTV. The results of this investigation
support the hypothesis that there is an
aetiologic relationship between mouse and
human breast carcinomas.
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